Affiliation:
1. Grupo de Investigación en Ciencias Animales—GRICA, Facultad de Medicina Veterinaria y Zootecnia, Universidad Cooperativa de Colombia, Bucaramanga 680002, Colombia
2. Grupo de Investigación en Microbiología Veterinaria, Escuela de Microbiología, Universidad de Antioquia UdeA, Medellín 050001, Colombia
Abstract
The use of azathioprine (AZA) in human medicine dates back to research conducted in 1975 that led to the development of several drugs, including 6-mercaptopurine. In 1958, it was shown that 6-mercaptopurine decreased the production of antibodies against earlier administered antigens, raising the hypothesis of an immunomodulatory effect. AZA is a prodrug that belongs to the thiopurine group of drugs that behave as purine analogs. After absorption, it is converted into 6-mercaptopurine. Subsequently, it can be degraded through various enzymatic pathways into inactive compounds and biologically active compounds related to the mechanism of action, which has been the subject of study to evaluate a possible antiviral effect. This study aims to examine the metabolism, mechanism of action, and antiviral potential of AZA and its derivatives, exploring AZA impact on antiviral targets and adverse effects through a narrative literature review. Ultimately, the review will provide insights into the antiviral mechanism, present evidence of its in vitro effectiveness against various DNA and RNA viruses, and suggest in vivo studies to further demonstrate its antiviral effects.
Reference65 articles.
1. The chemistry and biochemistry of purine analogs;Hitchings;Ann. N. Y. Acad. Sci.,1954
2. Elion, G.B., and Hitchings, G.H. (1975). Antineoplastic and Immunosuppressive Agents: Part II, Springer.
3. Mycophenolate mofetil, azathioprine and tacrolimus: Mechanisms in rheumatology;Broen;Nat. Rev. Rheumatol.,2020
4. 6-Mercaptopurine: An inhibitor of mouse sarcoma 180;Clarke;Proc. Am. Assoc. Cancer Res.,1953
5. 6-Mercaptopurine: Effects in mouse sarcoma 180 and in normal animals;Clarke;Cancer Res.,1953